Beyond p-values: a cross-sectional umbrella review of chemotherapy-induced peripheral neuropathy treatments
IntroductionChemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of neurotoxic chemotherapy agents, significantly impacting the daily lives of many cancer survivors. Despite thousands of articles published on CIPN, we remain no closer to a successful treatment regimen for the co...
Saved in:
| Main Authors: | Alice L. Ye, Salahadin Abdi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pain Research |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpain.2025.1564662/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The treatment of chemotherapy-induced peripheral neuropathy: a review of current management options and a potential role for scrambler therapy
by: Hassan Aboumerhi, et al.
Published: (2025-07-01) -
Impact of Exercise Training in Patients with Diabetic Peripheral Neuropathy: An Umbrella Review
by: Alba Gracia-Sánchez, et al.
Published: (2025-06-01) -
Interventions for primary prevention of cardiovascular disease: umbrella review of systematic reviews
by: Olalekan A Uthman, et al.
Published: (2024-06-01) -
Characteristics of Acupuncture Intervention for Chemotherapy-induced Peripheral Neuropathy Prevention: A Scoping Review of Clinical Trials
by: Alice Feng, et al.
Published: (2025-07-01) -
Neuroinflammation and сhemotherapy-induced peripheral neuropathy
by: P. I. Pilipenko, et al.
Published: (2022-04-01)